Brassinosteroid (BR) signaling is required for normal plant growth as shown by the dwarf phenotype of loss-of-function BR biosynthetic or perception mutants. Despite a detailed understanding of the BR signaling network [1] [2] [3] , it is not clear how exactly BRs control growth. For instance, genetic sector analysis shows that BRs, in contrast to most other growth regulators, act locally, presumably in an autocrine and/or paracrine mode, suggesting that they have some role in feedback regulation [4, 5] . Here, we show that at least one role for BRs in growth control is to ensure pectin-dependent cell wall homeostasis. Pectins are complex block cell wall polymers [6] , which can be modified in the wall by the enzyme pectin methylesterase (PME) [7] . Genetic or pharmacological interference with PME activity causes dramatic changes in growth behavior, which are primarily the result of the activation of the BR signaling pathway. We propose that this activation of BR signaling is part of a compensatory response, which protects the plant against the loss of cell wall integrity caused by the imbalance in pectin modification. Thus, feedback signaling from the cell wall is integrated by the BR signaling module to ensure homeostasis of cell wall biosynthesis and remodeling.
Results and Discussion
The growth of the wall-enclosed plant cell is driven by turgor pressure and controlled by the extensibility of the wall [8] . Several lines of evidence show that cell wall extensibility is in part controlled by pectin-dependent mechanisms. Homogalacturonan (HG), the most abundant pectin species, may form load-bearing Ca 2+ crosslinks in the wall upon demethylesterification by pectin methylesterase (PME). To analyze the effect of interference with PME activity on root growth and development, we utilized the catechin-derivative (-)-epigallocatechin gallate (EGCG), which was recently shown to be a potent inhibitor of PME activity [9] . After confirming that EGCG had an inhibitory effect on root PMEs in vitro (Figure S1A available online), we cultivated Arabidopsis Col-0 wild-type seedlings on medium supplemented with EGCG. In contrast to plants grown on control plates, EGCG-treated plants showed reduced root elongation and a root waving phenotype ( Figures 1A and 1B , and S1B), suggesting that regulated PME activity is important for maintaining the growth rate and direction. As we could not rule out that the observed phenotypes result from EGCG effects independent of PME inhibition, we pursued a complementary approach by overexpressing a PME inhibitor protein [10] , PMEI5 (At2g31430), in transgenic plants (referred to as PMEIox). As expected, FT-IR microspectroscopy revealed in the walls of PMEIox hypocotyls, a small but significant increase in the abundance of ester bonds, presumably corresponding to pectin methylesters (Figures S1E and S1F). These plants also showed pronounced irregular root waving, similar to the EGCG-induced phenotype ( Figures  1A and 1B) , with the difference that PMEI overexpression did not result in reduced root length ( Figure S1B ). Interestingly, root growth became totally erratic on the surface of tilted plates, conditions that promote root waving in the wild-type [11, 12] (Figure S1C ). For analysis of short-term responses, transgenic plants with inducible PMEI expression were generated (iPMEIox). After transfer to induction medium, root waving was observed as with the constitutive line. Interestingly, elevated concentrations of inducer provoked a phenotype even stronger than that observed with PMEIox plants ( Figures 1C and S1D) . A pronounced directional growth phenotype was also observed in adult PMEI transformants, which showed curled leaves, a convoluted shoot, and misshapen siliques ( Figures 1D and 1E ). In summary, surprisingly strong and multifaceted phenotypes were provoked by pharmacological or genetic interference with PME activity.
To investigate whether these phenotypes were a direct effect of altered pectin methylesterification patterns on the cell wall mechanics or the secondary consequence of a so far unknown pectin-dependent signaling pathway, we conducted a forward genetic screen to identify suppressor mutants of the PMEIox phenotype (exemplified in Figure S2A ), reasoning that suppressing mutants might reveal components of such a presumed signaling pathway. Here, we report the isolation of the comfortably numb1 (cnu1) mutant, in which most aspects of the PMEIox phenotype are suppressed (Figures 2A, 2B , S2B, and S2C). Through genetic mapping, we identified a mutation associated with the suppressor phenotype causing an amino acid change (G944D) in the kinase domain of the brassinosteroid (BR) receptor protein BRI1 [13] . This shows that, indeed, signaling could be involved in the PMEIox phenotype. In agreement with this, suppression of the PMEIox phenotype was also observed with other BRrelated mutants ( Figure S2D ). In addition, we crossed out cnu1 to the wild-type to obtain a bri1 mutant (termed bri1 cnu1 ) in the absence of the PMEIox transgene. Compared to published bri1 mutants, adult bri1 cnu1 plants showed a typical BR-deficient phenotype of intermediate strength ( Figures  S2B and S2C) .
BR perception by BRI1 activates the transcription factors BZR1 and 2 (also known as BES1) through inhibition of the GSK3-like kinase BIN2. BZR1 and 2, in turn, regulate a plethora of genes involved in cell wall biosynthesis and remodeling [1, 2, 14] . Because the transcription of BR biosynthesis genes such as DWF4 is inhibited by BZR1, the BR signaling module constitutes a negative feedback loop (overview in Figure 2C ). To explore whether BR signaling could be involved in the response to interference with PME activity, we germinated seeds of wild-type, PMEIox, and cnu1 on plates containing the BR 24-epi-brassinolide (BL) and grew them for 5 days.
Treatment with BL induced PMEIox-like root waving in the wild-type as observed previously [15] , whereas cnu1 was hardly affected ( Figures 2D and 2E ). Conversely, bikinin [16] , a chemical that activates BR signaling downstream of BRI1 ( Figure 2C ), induced root waving not only in the wild-type but also in cnu1, consistent with a functional complementation of the BR receptor defect ( Figures 2D and 2E ). We then performed similar experiments on seedlings grown in the dark, a condition under which PMEIox hypocotyls elongate agravitropically along the surface of horizontal agar plates (Figure 2F) . Interestingly, wild-type plants growing on medium supplemented with BL showed a phenotype strikingly similar to that of PMEIox plants with a twisted hypocotyl and agravitropic growth ( Figures 2G and 2H ). BL treatment also reduced the length of PMEIox hypocotyls, whereas, as expected for a mutant with a defective BR receptor, the cnu1 mutant was less responsive to the treatment ( Figures 2I and 2J) . Bikinin, on the other hand, induced PMEIox-like phenotypes in cnu1 hypocotyls with respect to appearance, gravitropism, and growth response ( Figures 2G, 2H , and 2J), again suggesting functional complementation of the BRI1 mutation. To corroborate these findings, we performed FT-IR analysis of cell wall chemistry. Consistent with the induction of a PMEIox-like phenotype, BL application significantly increased the ester levels in the cell walls of Col-0 seedlings ( Figures S2E-S2G ). Consistent with an elevated brassinosteroid signaling, PMEIox plants showed resistance to treatment with the BR biosynthesis inhibitor brassinazole (BRZ) compared to wild-type and cnu1 plants ( Figure S2H ). The direct target of BRZ, the steroid 22-alpha hydroxylase DWF4, is negatively regulated by brassinosteroid signaling at the transcriptional level; therefore, reduced DWF4 expression can be used as an indicator of BR signaling activation [17, 18] . In accordance with previous results, QRT-PCR analysis revealed a > 3-fold reduction of DWF4 expression in PMEIox plants, whereas the expression in cnu1 was almost identical to that in the wild-type ( Figure 2K ). An additional indication for an elevated BR signaling in PMEIox plants was provided by crossing the transformants with plants overexpressing a GFP-tagged version of BRI1, which further enhanced the PMEIox phenotype and resulted in extremely dwarfed plants with twisted organ growth (Figure 2L) . Enhanced BR signaling in PMEIox was not related to a detectable change in the abundance or the intracellular localization of the GFP-tagged BRI1 receptor, as shown by immunoblotting and comparison of the BRI1:GFP localization in a wild-type and PMEIox background ( Figures S2I and S2J ), respectively.
As our results suggested that BR signaling could be causative for the PMEIox phenotype, we analyzed whether induction of BR signaling preceded the appearance of the root waving phenotype in the iPMEIox line. QRT-PCR analysis revealed a rapid and strong induction of the PMEI transcript, whereas DWF4 expression remained stable for at least 2 hr after induction ( Figure S2K ). After 4 hr, DWF4 expression was reduced w40% and remained at a similar level until the end of the experiment at 24 hpi. In accordance with BR signaling being causative for the morphological changes, root waving did not occur until between 4 and 9 hr after induction ( Figures  S2L and S2M) . It has to be noted that any biochemical effect of PMEI presumably requires transport to the cell wall and the presence of both PME and methylesterified HG. Therefore, it is conceivable that only actively growing tissue is susceptible to PMEI induction.
We next analyzed whether EGCG also induced brassinosteroid signaling as previously demonstrated with PMEIox. Therefore, transgenic lines expressing the early brassinosteroid signaling marker BKI1:YFP [19] were subjected to EGCG treatment. BKI1 is an inhibitory protein that dissociates from BRI1 upon activation of the receptor. Thus, relocalization of BKI1 from the plasma membrane to the cytosol is indicative of elevated BR signaling. After 5 hr of EGCG treatment, membrane localization of BKI1:YFP was reduced in favor of cytosolic labeling specifically in the swollen cells (see below), and after 24 hr, YFP fluorescence was observed exclusively in the cytosol in all root cells ( Figure 3A) . This, together with reduced DWF4 expression ( Figure 3B ), confirmed that EGCG treatment triggered BR signaling. BR signaling causes the upregulation of a large number of genes encoding cell wall remodeling agents, including several PMEs. To evaluate the spatial expression pattern of PMEs that are upregulated by BR and known direct BZR1 targets [14] , we used promoter:: GUS reporter lines At3g49220 [20] and At3g14310 [21] . After transfer to EGCGcontaining medium, GUS activity was upregulated in the growing zone of the root and downregulated in the differentiated parts of the root ( Figure 3C ). This shows that, in growing cells, the inhibition of PME activity triggers the transcriptional upregulation of at least two PME genes through a BRI1-dependent feedback loop. Consistent with a role of BR signaling in PME regulation, elevated PME activity after treatment with BL and reduced PME activity in a bri1 mutant has been reported [22] .
To obtain independent confirmation for the involvement of BR signaling in phenotypes observed with PME inhibition, we analyzed various BR mutants in the presence of EGCG. Importantly, root waving of bri1 cnu1 seedlings on plates containing EGCG was strongly reduced compared to the wildtype ( Figure 3D ), and the same result was observed with bri1-5 [23] , bri1-301 [24] , and the brassinosteroid biosynthetic mutant det2-1 [25, 26] (Figures 3D and S3) .
In summary, our results suggest that elevated BR signaling is the main cause of the gross morphological phenotype observed after persistent pharmacological or genetic interference with PME activity. This would imply that the observable phenotypes are, to great extent, caused by a secondary response to the changed methylesterification status, possibly as a compensatory mechanism. Consistent with this, both antibody labeling of demethylesterified pectin and PME activity was reduced 2 hr after iPMEIox induction ( Figures  S4A-S4C ). These effects were almost completely alleviated at 24 hr after induction, i.e., after the onset of the BR-mediated compensatory response (Figures S2K-S2M) . Furthermore, we reasoned that applying a harsh EGCG treatment to plants that are impaired in BR signaling and, hence, unable to fully execute the compensatory reaction, could possibly reveal the primary effect of reduced PME activity and thus shed light on the target of the response. Therefore, EGCG was administered in liquid medium to Col-0, bri1 cnu1 , and det2-1 seedlings for 24 hr and the effect on root morphology was observed. The Col-0 wild-type seedlings showed cell swelling in the transition/elongation zone of the root tip, which was more pronounced in the bri1 cnu1 mutant. This effect was further increased in the strong det2-1 mutant, which showed marked cell swelling and a frequent cell detachment or rupture ( Figures  4A and 4B ). Similar to EGCG treatment, strong induction of PMEI expression for 2 hr, a time period too short for the activation of BR signaling ( Figures S2I and S2J ), led to cell swelling in the root transition/elongation zone of iPMEIox plants (Figure 4C ). This suggests that the loss of cell wall integrity or a defective regulation of cell wall extensibility in susceptible cells is the primary effect of a reduction in PME activity. BR signaling could then be activated after sensing of either the cell swelling or changes in the cell wall itself. Arguing against the former, we did not find any evidence for an effect of altered osmotic conditions on the PMEI phenotype or BR signaling ( Figures S4D-S4F ).
The following model can be proposed to explain our results ( Figure 4D ). The integrity of the cell walls of growing cells requires a balance between processes that respectively promote cell wall relaxation (e.g., removal of Ca 2+ /pectate crosslinks) and stiffening (e.g., generation of new Ca 2+ /pectate crosslinks) [27] [28] [29] [30] . Interfering with PME activity (through EGCG treatment or PMEI expression) would lead to a reduction of pectate in the cell wall, which would cause the activation of the BRI1 receptor through a so far unknown feedback mechanism and the compensatory upregulation of wall remodeling agents including PMEs. Interestingly, perturbation of Ca 2+ / pectate crosslinks by an excess of monovalent cations [31] , for instance during environmental stresses such as salinity or drought, might also activate such BR-mediated compensation mechanisms and explain, at least in part, the increased resistance of BR-treated plants to various abiotic stresses [32] . 
